March 7th 2023
ACC 2023. In the CLEAR Outcomes trial, bempedoic acid reduced risk for major CV events by 13% compared with placebo in patients who had, or were at high risk for, CVD.
March 7th 2023
ACC2023. For high-risk T2D patients not receiving optimal treatment for hyperlipidemia, hypertension, or hyperglycemia, intensive, multidisciplinary training for clinic staff could shift practice.
March 3rd 2023
ACC 2023. The Mediterranean diet has a beneficial effect on the primary prevention of cardiovascular disease and death in women, according to new analysis.
March 1st 2023
ACC 2023. Results from a 2-decade study showed that all-cause mortality rates were significantly higher in patients with obesity with uncontrolled HTN compared to those without HTN.
February 28th 2023
ACC 2023. In an analysis of patients with heart failure, never having been married was associated with worse survival compared with having been married.
February 28th 2023
ACC 2023. A large study found increased risk for MI regardless of age and detected particularly heightened risk among women and persons with diabetes who have insomnia.
February 28th 2023
ACC 2023. New study found cognitive behavioral therapy delivered via mobile app significantly reduced HbA1c and need for antihyperglycemic intensification compared to use of a control app.
February 24th 2023
ACC 2023. Daily marijuana users were 34% more likely to have coronary artery disease than never-users, according to new research.
February 24th 2023
AAAAI 2023. The TSLP inhibitor was superior to placebo in 2 post hoc analyses of the PATHWAY and NAVIGATOR clinical trials.
February 23rd 2023
Future studies may consider PARS the new gold standard in predicting pediatric asthma risk, said study authors.